Cargando…

Targeting Aggressive Pituitary Adenomas at the Molecular Level—A Review

Pituitary adenomas (PAs) are mostly benign endocrine tumors that can be treated by resection or medication. However, up to 10% of PAs show an aggressive behavior with invasion of adjacent tissue, rapid proliferation, or recurrence. Here, we provide an overview of target structures in aggressive PAs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Voellger, Benjamin, Zhang, Zhuo, Benzel, Julia, Wang, Junwen, Lei, Ting, Nimsky, Christopher, Bartsch, Jörg-Walter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745122/ https://www.ncbi.nlm.nih.gov/pubmed/35011868 http://dx.doi.org/10.3390/jcm11010124

Ejemplares similares

Selective estrogen receptor modulators decrease invasiveness in pituitary adenoma cell lines AtT‐20 and TtT/GF by affecting expression of MMP‐14 and ADAM12
por: Zhang, Zhuo, et al.
Publicado: (2020)

Pituitary Adenoma Volumetry with 3D Slicer
por: Egger, Jan, et al.
Publicado: (2012)

PDCD10 promotes the aggressive behaviors of pituitary adenomas by up-regulating CXCR2 and activating downstream AKT/ERK signaling
por: Liu, Jingdian, et al.
Publicado: (2022)

Pituitary Crooke Cell Adenoma: Two Cases of an Aggressive Pituitary Adenoma
por: Taiwo, Adeyinka, et al.
Publicado: (2023)

Surgical treatment of aggressive pituitary adenomas and pituitary carcinomas
por: Buchfelder, Michael, et al.
Publicado: (2020)

Temozolomide in aggressive pituitary adenomas and carcinomas
por: Ortiz, Leon D., et al.
Publicado: (2012)

Use of Neuronavigation and Augmented Reality in Transsphenoidal Pituitary Adenoma Surgery
por: Bopp, Miriam H. A., et al.
Publicado: (2022)

Lessons Learned from Developing Digital Teaching Modules for Medical Student Education in Neurosurgery during the COVID-19 Pandemic
por: Rupa, Rosita, et al.
Publicado: (2021)

Resveratrol decreases B-cell lymphoma-2 expression and viability in GH3 pituitary adenoma cells of the rat
por: Voellger, Benjamin, et al.
Publicado: (2013)

Outcome after Interdisciplinary Treatment for Aneurysmal Subarachnoid Hemorrhage—A Single Center Experience
por: Voellger, Benjamin, et al.
Publicado: (2019)

Dynamics in the Neurotrauma Catchment Area of a German University Hospital during the COVID-19 Pandemic
por: Rupa, Rosita, et al.
Publicado: (2022)

Spine Surgery Supported by Augmented Reality
por: Carl, Barbara, et al.
Publicado: (2020)

The Demand for Elective Neurosurgery at a German University Hospital during the First Wave of COVID-19
por: Rupa, Rosita, et al.
Publicado: (2020)

Treatment of Aggressive Pituitary Adenomas: A Case-Based Narrative Review
por: Cooper, Odelia, et al.
Publicado: (2021)

An Aggressive Plurihormonal Pituitary Adenoma With Thyrotropin, Growth Hormone, and Prolactin Excess
por: Goh, QingCi, et al.
Publicado: (2023)

The Molecular Pathogenesis of Pituitary Adenomas: An Update
por: Jiang, Xiaobing, et al.
Publicado: (2013)

Targeting the Tumor Immune Microenvironment Could Become a Potential Therapeutic Modality for Aggressive Pituitary Adenoma
por: Yang, Zuocheng, et al.
Publicado: (2023)

Editorial: Targeted Therapy for Pituitary Adenomas
por: Araki, Takako, et al.
Publicado: (2019)

In1-ghrelin splicing variant is overexpressed in pituitary adenomas and increases their aggressive features
por: Ibáñez-Costa, Alejandro, et al.
Publicado: (2015)

MON-467 Expression of Somatostatin Receptors in Aggressive Non-Functioning Pituitary Adenomas
por: Soto, Alfonso, et al.
Publicado: (2019)

SUN-272 Significant Response to Temozolomide in Two Aggressively Growing Pituitary Adenomas
por: Kreitschmann-Andermahr, Ilonka, et al.
Publicado: (2020)

Early Initiation of Temozolomide Therapy May Improve Response in Aggressive Pituitary Adenomas
por: Das, Liza, et al.
Publicado: (2021)

Clinicopathological Characteristics of Plurihormonal Pituitary Adenoma
por: Shi, Ruoyu, et al.
Publicado: (2022)

Pituitary Adenoma Surgery Survey: Neurosurgical Centers and Pituitary Adenomas
por: Netuka, David, et al.
Publicado: (2022)

Editorial: Molecular Network Study of Pituitary Adenomas
por: Zhan, Xianquan, et al.
Publicado: (2020)

Treatment of Aggressive Prolactin-Secreting Pituitary Adenomas with Adjuvant Temozolomide Chemotherapy: A Review
por: Moisi, Marc, et al.
Publicado: (2016)

MON-255 Oral Contraceptive Pills Mask an Aggressive Crooke’s Cell Pituitary Adenoma
por: Gnanapragasam, Helen Prathiba, et al.
Publicado: (2020)

MON-269 FGFR-4 Expression in Pituitary Adenomas Is Associated with Aggressive Tumor Features
por: Kadioglu, Pinar, et al.
Publicado: (2020)

Histological criteria for atypical pituitary adenomas – data from the German pituitary adenoma registry suggests modifications
por: Miermeister, Christian P., et al.
Publicado: (2015)

Cytology of Pituitary Adenomas
por: Doniach, I.
Publicado: (1972)

The Epigenomics of Pituitary Adenoma
por: Hauser, Blake M., et al.
Publicado: (2019)

The Genetics of Pituitary Adenomas
por: Tatsi, Christina, et al.
Publicado: (2019)

Molecular Markers of Telomerase Complex for Patients with Pituitary Adenoma
por: Gedvilaite, Greta, et al.
Publicado: (2022)

LBMON174 Germline Molecular Genetics Of Pituitary Adenomas
por: Alzahrani, Ali, et al.
Publicado: (2022)

The Predictive Value of Pathologic Features in Pituitary Adenoma and Correlation with Pituitary Adenoma Recurrence
por: Kim, Jee Soon, et al.
Publicado: (2016)

Erratum: Histological criteria for atypical pituitary adenomas – data from the German pituitary adenoma registry suggests modifications
por: Miermeister, Christian P., et al.
Publicado: (2016)

Outcomes and Complications of Aggressive Resection Strategy for Pituitary Adenomas in Knosp Grade 4 With Transsphenoidal Endoscopy
por: Ouyang, Taohui, et al.
Publicado: (2021)

Gene expression profiling analysis of MENX-associated rat pituitary adenomas contributes to understand molecular mechanisms of human pituitary adenomas
por: ZHANG, HONGZHI, et al.
Publicado: (2016)

Identification and Verification of SLC27A1, PTBP1 and EIF5A With Significantly Altered Expression in Aggressive Pituitary Adenomas
por: Cheng, Jianhua, et al.
Publicado: (2022)

Transcriptome analysis of MENX-associated rat pituitary adenomas identifies novel molecular mechanisms involved in the pathogenesis of human pituitary gonadotroph adenomas
por: Lee, Misu, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_q68id90s50edio7ntilm7jph6s